טרסבה 150 מג ישראל - עברית - Ministry of Health

טרסבה 150 מג

roche pharmaceuticals (israel) ltd - erlotinib as dihydrochloride - טבליות מצופות פילם - erlotinib as dihydrochloride 150 mg - erlotinib - erlotinib - tarceva is indicated for the treatment of patients with locally advanced or metastatic non - small cell lung cancer after failure of at least one prior chemotherapy regimen. tarceva is indicated in combination with gemcitabine for the first-line treatment of patients with locally advanced unresectable or metastatic pancreatic cancer.tarceva® monotherapy is indicated for the maintenance treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) whose disease has not progressed after four cycles of platinum-based first-line chemotherapy. tarceva is indicated for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with egfr activating mutations.

טרסבה 100 מג ישראל - עברית - Ministry of Health

טרסבה 100 מג

roche pharmaceuticals (israel) ltd - erlotinib as dihydrochloride - טבליות מצופות פילם - erlotinib as dihydrochloride 100 mg - erlotinib - erlotinib - tarceva is indicated for the treatment of patients with locally advanced or metastatic non - small cell lung cancer after failure of at least one prior chemotherapy regimen. tarceva is indicated in combination with gemcitabine for the first-line treatment of patients with locally advanced unresectable or metastatic pancreatic cancer.tarceva® monotherapy is indicated for the maintenance treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) whose disease has not progressed after four cycles of platinum-based first-line chemotherapy. tarceva is indicated for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with egfr activating mutations.

סלספט 250 מג ישראל - עברית - Ministry of Health

סלספט 250 מג

roche pharmaceuticals (israel) ltd - mycophenolate mofetil - קפסולות - mycophenolate mofetil 250 mg - mycophenolic acid - mycophenolic acid - prophylaxis of rejection in renal allograft recepients, and in patients reciving allogenic cardiac transplants. cellcept should be used concomitantly with cyclosporin and corticosteroids.allogenic hepatic transplant.

סלספט 500 מג ישראל - עברית - Ministry of Health

סלספט 500 מג

roche pharmaceuticals (israel) ltd - mycophenolate mofetil - טבליות מצופות פילם - mycophenolate mofetil 500 mg - mycophenolic acid - mycophenolic acid - prophylaxis of rejection in renal allograft recepients, and in patients reciving allogenic cardiac transplants. cellcept should be used concomitantly with cyclosporin and corticosteroids.allogenic hepatic transplant.

אתופן 400 ישראל - עברית - Ministry of Health

אתופן 400

taro pharmaceutical industries ltd - etodolac - טבליה - etodolac 400 mg - etodolac - etodolac - for the management of signs and symptoms of osteoarthritis and rheumatoid arthritis. for the management of pain.

אתופן 200 ישראל - עברית - Ministry of Health

אתופן 200

taro pharmaceutical industries ltd - etodolac - קפסולות - etodolac 200 mg - etodolac - etodolac - for the management of signs and symptoms of osteoarthritis and rheumatoid arthritis. for the management of pain.

אתופן 300 ישראל - עברית - Ministry of Health

אתופן 300

taro pharmaceutical industries ltd - etodolac - קפסולות - etodolac 300 mg - etodolac - etodolac - for the management of signs and symptoms of osteoarthritis and rheumatoid arthritis. for the management of pain.

אתופן 500 ישראל - עברית - Ministry of Health

אתופן 500

taro pharmaceutical industries ltd - etodolac - טבליה - etodolac 500 mg - etodolac - etodolac - for the managament of signs and symptoms of osteoarthritis and rheumatoid arthritis.for the management of pain.

לוסנטיס ישראל - עברית - Ministry of Health

לוסנטיס

novartis israel ltd - ranibizumab - תמיסה להזרקה - ranibizumab 10 mg/ml - ranibizumab - ranibizumab - treatment of patients with neovascular (wet) age-related macular degeneration (amd).treatment of adult patients with visual impairment due to diabetic macular oedema (dme) .the treatment of visual impairement due to macular oedema secondary to retinal vein occulsion (rvo).the treatment of visual impaiment due to choroidal neovacularization (cnv) secondary to pathologic myopia (pm).